SIPHA Share Price Performance
د.ت4.66
-0.03 (-0.64%)
Price د.ت4.66
Share Pricen/a
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
SIPHA Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Société des Industries Pharmaceutiques de Tunisie - S.A. Key Details
About SIPHA
- Founded
- 1989
- Employees
- n/a
- CEO
- WebsiteView website
Société des Industries Pharmaceutiques de Tunisie - S.A. engages in the research, development, manufacture, packaging, and marketing of pharmaceutical products for human use in Tunisia and internationally. It provides rheumatology drugs, such as MYORELAX, NIFLUMIC, and ALGESAL SURACTIVE; stomatology drugs, including HEXABAIN; and ANALGAN CODEINE 300mg/25mg indicated for the symptomatic treatment of moderate and intense pain. The company was founded in 1989 and is headquartered in Ben Arous, Tunisia.